(S) - (+) -3- hydroxy tetrahydrofuran can be used for first-line treatment of advanced non-small cell lung cancer (NSCLC) and intermediate for HER2 positive breast cancer patients, the intermediate of afatinib, the intermediate of afatinib.
As an organic synthesis, it is an important intermediate for the treatment of AIDS drugs and antiviral drugs.